BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29228320)

  • 1. Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma.
    Imamura T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Ohashi T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Carcinogenesis; 2018 Feb; 39(2):263-271. PubMed ID: 29228320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.
    Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Br J Cancer; 2017 Jan; 116(2):218-226. PubMed ID: 27898655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of denticleless E3 ubiquitin protein ligase homolog (DTL) is related to poor outcome in gastric carcinoma.
    Kobayashi H; Komatsu S; Ichikawa D; Kawaguchi T; Hirajima S; Miyamae M; Okajima W; Ohashi T; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Oncotarget; 2015 Nov; 6(34):36615-24. PubMed ID: 26472028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
    Aratani K; Komatsu S; Ichikawa D; Ohashi T; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Anticancer Res; 2017 Jun; 37(6):3129-3135. PubMed ID: 28551654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma.
    Nishimura Y; Komatsu S; Ichikawa D; Nagata H; Hirajima S; Takeshita H; Kawaguchi T; Arita T; Konishi H; Kashimoto K; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Br J Cancer; 2013 Apr; 108(6):1324-31. PubMed ID: 23422756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of SMYD2 contributes to malignant outcome in gastric cancer.
    Komatsu S; Ichikawa D; Hirajima S; Nagata H; Nishimura Y; Kawaguchi T; Miyamae M; Okajima W; Ohashi T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Imoto I; Inazawa J; Otsuji E
    Br J Cancer; 2015 Jan; 112(2):357-64. PubMed ID: 25321194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
    Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
    Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction.
    Aratani K; Komatsu S; Ichikawa D; Ohashi T; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Oncotarget; 2017 Oct; 8(48):84112-84122. PubMed ID: 29137409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
    Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
    Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling.
    Liu F; Cao QH; Lu DJ; Luo B; Lu XF; Luo RC; Wang XG
    Oncotarget; 2015 May; 6(13):11585-99. PubMed ID: 25839162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma.
    Kashimoto K; Komatsu S; Ichikawa D; Arita T; Konishi H; Nagata H; Takeshita H; Nishimura Y; Hirajima S; Kawaguchi T; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Cancer Sci; 2012 Nov; 103(11):2021-6. PubMed ID: 22862969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer.
    Nishibeppu K; Komatsu S; Kiuchi J; Kishimoto T; Takashima Y; Shoda K; Arita T; Kosuga T; Konishi H; Shiozaki A; Kubota T; Okamoto K; Fujiwara H; Tsuda H; Otsuji E
    J Cancer; 2021; 12(2):316-325. PubMed ID: 33391428
    [No Abstract]   [Full Text] [Related]  

  • 13. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of YEATS4 contributes to malignant outcomes in gastric carcinoma.
    Kiuchi J; Komatsu S; Imamura T; Nishibeppu K; Shoda K; Arita T; Kosuga T; Konishi H; Shiozaki A; Kubota T; Okamoto K; Fujiwara H; Ichikawa D; Tsuda H; Otsuji E
    Am J Cancer Res; 2018; 8(12):2436-2452. PubMed ID: 30662802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of ribophorine II is a promising prognostic factor in human gastric adenocarcinoma.
    Fujimoto D; Goi T; Hirono Y
    Int J Oncol; 2017 Feb; 50(2):448-456. PubMed ID: 28035352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low level of FOXL1 indicates a worse prognosis for gastric cancer patients.
    Ertao Z; Jianhui C; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C; Hui W
    Tumour Biol; 2016 Aug; 37(8):11331-7. PubMed ID: 26960689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
    Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
    BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of miR-425-5p detection and its association with cell proliferation and apoptosis of gastric cancer.
    Zhang Z; Wen M; Guo J; Shi J; Wang Z; Tan B; Zhang G; Zheng X; Zhang A
    Pathol Res Pract; 2017 Aug; 213(8):929-937. PubMed ID: 28647207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer.
    Takashima Y; Komatsu S; Ohashi T; Kiuchi J; Kamiya H; Shimizu H; Arita T; Konishi H; Shiozaki A; Kubota T; Okamoto K; Fujiwara H; Tsuda H; Otsuji E
    Cancer Sci; 2022 Jun; 113(6):1984-1998. PubMed ID: 35307915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.